EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway

Li Zhang, Yong-Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong, Jia Ding, Zhong-Hua Wang, Yu-Li Wang, Xiu-Ping Liu, Fa-Xing Yu, Jian Wu iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Li Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology & Parasitology, MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan…. Hauptthemen laut MEDLINE: Liver Regeneration, Liver Transplantation, Cell Adhesion Molecules. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shanghai Commission of Sciences and Technologies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Liver regeneration retardation post partial hepatectomy (PH) is a common clinical problem after liver transplantation. Identification of key regulators in liver regeneration post PH may be beneficial for clinically improving the prognosis of patients after liver transplantation. This study aimed to clarify the function of junctional protein‐associated with coronary artery disease (JCAD) in liver regeneration post PH and to reveal the underlying mechanisms.

Methods

JCAD knockout (JCAD‐KO), liver‐specific JCAD‐KO ( Jcad △Hep ) mice and their control group were subjected to 70% PH. RNA sequencing was conducted to unravel the related signalling pathways. Primary hepatocytes from KO mice were treated with epidermal growth factor (EGF) to evaluate DNA replication. Fluorescent ubiquitination‐based cell cycle indicator (FUCCI) live‐imaging system was used to visualise the phases of cell cycle.

Results

Both global and liver‐specific JCAD deficiency postponed liver regeneration after PH as indicated by reduced gene expression of cell cycle transition and DNA replication. Prolonged retention in G1 phase and failure to transition over the cell cycle checkpoint in JCAD‐KO cell line was indicated by a FUCCI live‐imaging system as well as pharmacologic blockage. JCAD replenishment by adenovirus reversed the impaired DNA synthesis in JCAD‐KO primary hepatocyte in exposure to EGF, which was abrogated by a Yes‐associated protein (YAP) inhibitor, verteporfin. Mechanistically, JCAD competed with large tumour suppressor 2 (LATS2) for WWC1 interaction, leading to LATS2 inhibition and thereafter YAP activation, and enhanced expression of cell cycle‐associated genes.

Conclusion

JCAD deficiency led to delayed regeneration after PH as a result of blockage in cell cycle progression through the Hippo–YAP signalling pathway. These findings uncovered novel functions of JCAD and suggested a potential strategy for improving graft growth and function post liver transplantation. Key Points JCAD deficiency leads to an impaired liver growth after PH due to cell division blockage. JCAD competes with LATS2 for WWC1 interaction, resulting in LATS2 inhibition, YAP activation and enhanced expression of cell cycle‐associated genes. Delineation of JCADHippoYAP signalling pathway would facilitate to improve prognosis of acute liver failure and graft growth in living‐donor liver transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver RegenerationLiver TransplantationCell Adhesion MoleculesAnimalsHumansMiceEpidermal Growth FactorIntracellular Signaling Peptides and ProteinsLiverLiving DonorsProtein Serine-Threonine KinasesTumor Suppressor Proteins

Stichwörter der Autor:innen

Hippo–YAP signalling pathwayJCADWWC1cell cycle phase visualisationliver regeneration

Substanzen

Epidermal Growth FactorIntracellular Signaling Peptides and ProteinsLATS2 protein, humanProtein Serine-Threonine KinasesTumor Suppressor ProteinsWWC1 protein, humanJCAD protein, mouseCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Medical Microbiology & Parasitology, MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University Shanghai Medical College, Shanghai, China.
  • Institute of Pediatrics, Children's Hospital of Fudan University, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fud…
  • Jing'an Central District Hospital, Shanghai, China.
  • Department of Pathology and Laboratory Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Department of Gastroenterology & Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.
  • Shanghai Institute of Liver Diseases, Fudan University Shanghai Medical College, Shanghai, China.

ORCID-Profile: Jian Wu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Shanghai Commission of Sciences and Technologies
  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Municipal Health Commission

Zitieren

APA

Zhang, L., Yang, Y. Y., Xie, L., Zhou, Y., Zhong, Z., Ding, J., Wang, Z. H., Wang, Y. L., Liu, X. P., Yu, F. X., & Wu, J. (2024). JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1630

Vancouver

Zhang L, Yang YY, Xie L, Zhou Y, Zhong Z, Ding J, et al. JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1630

BibTeX
@article{Zhang2024,
  author = {Zhang, Li and Yang, Yong-Yu and Xie, Li and Zhou, Yuan and Zhong, Zhenxing and Ding, Jia and Wang, Zhong-Hua and Wang, Yu-Li and Liu, Xiu-Ping and Yu, Fa-Xing and Wu, Jian},
  title = {JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1630}
}
Kostenlos starten →